《盈喜》飛魚科技(01022.HK)料中期虧轉盈 除稅後純利介乎約5,500萬至7,000萬人幣
飛魚科技(01022.HK)發盈喜,預期截至今年6月底止六個月將錄得除稅後純利介乎約5,500萬至7,000萬元人民幣,而去年同期則錄除稅後虧損淨額約200萬元人民幣。
董事會認為,期內虧轉盈主要是由於收益大幅增長,而收益大幅增長主要源於「一步兩步」,該遊戲於去年下半年推出,並於今年上半年進入回收週期,其前期營銷工作取得可觀回報;及預計期內確認集團於一間非上市有限合夥企業投資的投資收益介乎約30萬至100萬元人民幣,而去年同期則確認該非上市有限合夥企業的投資虧損約1,160萬元人民幣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.